THE AFATINIB DIARIES

etrasimod, nilotinib. Either improves results of one other by immunosuppressive results; risk of infection. Prevent or Use Alternate Drug. Danger of additive immune system consequences with etrasimod has not been analyzed in combination with antineoplastic, immune-modulating, or noncorticosteroid immunosuppressive therapies. Stay clear of coadminis